Your session is about to expire
What is Metreton
PrednisoneThe Generic name of this drug
Treatment SummaryDiphenhydramine is an antihistamine medication used to treat allergies, hay fever, and asthma. It is commonly used to reduce the symptoms of itching, sneezing, and runny nose. It is less likely to cause drowsiness than other similar medications and is often used in veterinary medicine.
PredniSONEis the brand name
Metreton Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
PredniSONE
Prednisone
1972
681
Approved as Treatment by the FDA
Prednisone, commonly known as PredniSONE, is approved by the FDA for 55 uses which include Anemia, Hemolytic and Thrombocytopenia .Anemia, Hemolytic
Thrombocytopenia
Conjunctivitis
Helps manage Ocular Inflammation
Atopic Dermatitis
Helps manage Atopic Dermatitis
Idiopathic Nephrotic Syndrome
Ulcerative Colitis
Helps manage Ulcerative Colitis
Disseminated tuberculosis
Used to treat Disseminated tuberculosis in combination with Aminosalicylic acid
Stevens-Johnson Syndrome
Contact Dermatitis
Uremia
Malignant Neoplasms
Mycosis Fungoides (MF)
Helps manage Mycosis Fungoides (MF)
induction of Diuresis
Mycosis Fungoides
Helps manage Mycosis Fungoides (MF)
Sarcoidosis
Helps manage symptomatic Sarcoidosis
Thyroiditis
Secondary adrenocortical insufficiency
Secondary thrombocytopenia
Ocular Inflammation
Helps manage Ocular Inflammation
Adrenal Cortex Hormones
Helps manage unresponsive to topical corticosteroids
Trichinosis
Congenital Hypoplastic Anemia
Systemic Lupus Erythematosus (SLE)
Congenital Adrenal Hyperplasia (CAH)
Neurologic Involvement
symptomatic Sarcoidosis
Helps manage symptomatic Sarcoidosis
non-suppurative Thyroiditis
Immune Thrombocytopenia (ITP)
Crohn Disease
Helps manage acute Crohn's Disease (CD)
Drug hypersensitivity reaction
Primary adrenocortical insufficiency
Ulcerative Colitis
Helps manage Ulcerative Colitis
Asthma
Helps manage Asthma
Pemphigus
Helps manage Pemphigus
acquired immune hemolytic anemia
Diuresis
Pemphigus
Helps manage Pemphigus
Allergic Rhinitis (AR)
Helps manage Allergic Rhinitis (AR)
Adrenal Insufficiency
Addison Disease
Uremia
Lupus Erythematosus
Proteinuria
Bullous dermatitis herpetiformis
Helps manage Bullous dermatitis herpetiformis
Tuberculosis
Used to treat fulminating Tuberculosis in combination with Aminosalicylic acid
Serum Sickness
exfoliative erythroderma
Helps manage exfoliative erythroderma
Patient Participation
Anemia, Diamond-Blackfan
Lupus
Congenital adrenal hyperplasia
Tuberculosis
Used to treat Disseminated tuberculosis in combination with Aminosalicylic acid
Aspiration Pneumonitis
Drug Allergy
Asthma
Helps manage Asthma
Effectiveness
How Metreton Affects PatientsAllergies happen when an allergen (like pollen) interacts with and activates the antibodies on mast cells and basophils. This causes these cells to release histamine and other chemical mediators, which can cause itching, flushing, headaches, a racing heart rate, and other symptoms. Chlorpheniramine is a drug that works by blocking the histamine receptors in the body, which helps to reduce the symptoms of allergies like sneezing, runny nose, itchy eyes, and watery eyes.
How Metreton works in the bodyChlorpheniramine blocks the effects of histamine, which reduces the symptoms of allergies. It does this by attaching to the histamine H1 receptor and preventing it from responding to histamine.
When to interrupt dosage
The suggested measure of Metreton depends upon the determined condition, including upper respiratory indications, Coughing and Inflammation. The amount of dosage is contingent upon the administration technique (e.g. Kit; Syrup - Oral or Liquid - Oral) featured in the table beneath.Condition
Dosage
Administration
Dermatomyositis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
prophylaxis of graves ophthalmopathy
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Craniotomy
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
exfoliative erythroderma
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Addison Disease
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
varicella-zoster virus acute retinal necrosis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Psoriasis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Trichinosis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
induction of Diuresis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Diuresis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Sarcoidosis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Brain
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Brain
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Optic Neuritis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Congenital adrenal hyperplasia
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Malignant Neoplasms
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
HIV Positive
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Red-Cell Aplasia, Pure
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Psoriatic Arthritis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Ulcerative Colitis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Solution, Oral, Solution - Oral, Tablet, Tablet - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Kit
Warnings
Metreton ContraindicationsCondition
Risk Level
Notes
Mycoses
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Prednisone may interact with Pulse Frequency
Common Metreton Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abatacept
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with Abatacept.
Abetimus
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with Abetimus.
Acteoside
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with Acteoside.
Metreton Toxicity & Overdose RiskThe lowest toxic dose of the drug for rats, mice, and guinea pigs has been found to be 306mg/kg, 130mg/kg, and 198mg/kg, respectively. It can also cause mild reproductive harm to women of childbearing age.
Metreton Novel Uses: Which Conditions Have a Clinical Trial Featuring Metreton?
163 active trials are currently underway to evaluate the potential of Metreton to reduce Allergy symptoms from vaccines, Eye issues, and Coughing.Condition
Clinical Trials
Trial Phases
Asthma
89 Actively Recruiting
Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 1, Phase 3
Metastatic Brain Tumors
60 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 3, Phase 4
Patient Participation
0 Actively Recruiting
Giant Cell Arteritis
3 Actively Recruiting
Phase 3, Phase 1, Phase 2
Stevens-Johnson Syndrome
2 Actively Recruiting
Phase 3, Phase 1
Tuberculosis
0 Actively Recruiting
Brain
0 Actively Recruiting
Seborrheic dermatitis
0 Actively Recruiting
Drug Allergy
3 Actively Recruiting
Phase 3, Phase 2, Phase 4
Craniotomy
0 Actively Recruiting
HIV Positive
0 Actively Recruiting
Bronchiolitis
0 Actively Recruiting
prophylaxis of graves ophthalmopathy
0 Actively Recruiting
Brain
7 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1
Acne Vulgaris
9 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4
Lupus
57 Actively Recruiting
Phase 2, Phase 1, Not Applicable, Phase 3, Phase 4
Acute Coryza
0 Actively Recruiting
acute Bursitis
0 Actively Recruiting
Chorioretinitis
0 Actively Recruiting
Tennis Elbow
0 Actively Recruiting
Metreton Reviews: What are patients saying about Metreton?
5Patient Review
11/4/2022 This medication has been a lifesaver for me. I've been taking it for anxiety and depression for about a year now, and it really makes a difference. It calms my mind and allows me to get a good night's sleep, which is something that was previously impossible for me. If you're struggling with anxiety, I would highly recommend giving this treatment a try.
5Patient Review
10/11/2022 I'm 82 years old and have battled depression my entire life. This medication has made me feel incredible, and I would recommend it to anyone. Thank you, Mirtazapine!
5Patient Review
11/4/2022 I've been taking 7.5mg of this medication for about a year to help with anxiety and mild depression. It definitely takes the edge off and helps me sleep at night, which is amazing. I would recommend it to anyone struggling with similar issues.
5Patient Review
10/11/2022 I am an 82 year old woman who has struggled with depression for my entire life. This medication has made me feel better than ever before and I would recommend it to anyone. Thank you Mirtazapine!
5Patient Review
11/4/2022 This dosage of medication has really helped me to cope with my anxiety and depression. It doesn't make me drowsy, but rather allows me to wake feeling refreshed after a good night's sleep. I recommend giving it a try if anxiety is keeping you up at night.
Patient Q&A Section about metreton
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Clinical Trials for Metreton
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.